Novo Nordisk Tresiba® FlexTouch® Insulin Degludec Injection Instructions for Use

Tresiba® FlexTouch® insulin degludec injection instructions for use, indicated for the treatment of adult type 2 diabetes mellitus


Novo Nordisk Tresiba® FlexTouch® Insulin Degludec Injection Instructions for Use - cover page
Brand
Novo Nordisk
Category
Health Care
Document type
User Manual
Language
Chinese
Pages
24
File format
PDF
File size
980 KB
Published
29 October, 2023
Updated
29 October, 2023
MD5 checksum
BC66A266C3020C1C6189ADC44F834463

About this manual

This document provides detailed instructions for using Tresiba® FlexTouch® insulin degludec injection to treat type 2 diabetes. It covers dosage, administration methods, precautions, and adverse reactions. The product is administered subcutaneously once daily, with dosage adjusted based on individual patient needs. It is not for intravenous or intramuscular use.

The document also includes information on potential side effects such as hypoglycemia, injection site reactions, and weight gain, along with guidance on managing these risks. It advises patients to rotate injection sites to reduce the risk of fat metabolism disorders and to monitor blood glucose levels closely during dose adjustments or when switching from other insulin therapies. This manual is written in Chinese.

What's inside

  • Drug Name and Composition
  • Indications
  • Dosage and Administration
  • Injection Site and Technique
  • Adverse Reactions
  • Contraindications
  • Precautions
  • Storage and Handling

Specifications

Active IngredientInsulin Degludec
Concentration100 U/ml
Volume per Pen3 ml
Dosage FormSubcutaneous Injection
Storage ConditionDo not freeze

Frequently asked questions

How often should Tresiba® FlexTouch® be administered?

Once daily, at any time of day, preferably at the same time each day.

Can Tresiba® FlexTouch® be used in elderly patients?

Yes, it can be used in elderly patients (≥65 years).

What should be done if a dose is missed?

Administer the missed dose immediately upon discovery, then continue with the regular daily schedule.

What are the common side effects of Tresiba® FlexTouch®?

The most common side effect is hypoglycemia (low blood sugar).

Download PDF (980 KB)

More Novo Nordisk Manuals


View all Novo Nordisk manuals →